Kay Tyerman

855 total citations
20 papers, 260 citations indexed

About

Kay Tyerman is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Kay Tyerman has authored 20 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in Kay Tyerman's work include Childhood Cancer Survivors' Quality of Life (5 papers), Dialysis and Renal Disease Management (5 papers) and Adolescent and Pediatric Healthcare (3 papers). Kay Tyerman is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (5 papers), Dialysis and Renal Disease Management (5 papers) and Adolescent and Pediatric Healthcare (3 papers). Kay Tyerman collaborates with scholars based in United Kingdom, United States and Finland. Kay Tyerman's co-authors include Maggie Fitzpatrick, John H. McColl, Ian J. Ramage, Stephen Pollard, John Geen, Aled O. Phillips, Jennifer Holmes, John D. Williams, Sam Douthwaite and Bob Phillips and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Archives of Disease in Childhood.

In The Last Decade

Kay Tyerman

20 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Tyerman United Kingdom 10 116 80 58 49 43 20 260
Wai Leung Chak China 11 91 0.8× 38 0.5× 32 0.6× 63 1.3× 18 0.4× 21 286
L. Benamar Morocco 10 95 0.8× 35 0.4× 27 0.5× 36 0.7× 14 0.3× 93 323
Covadonga Hevia Spain 12 282 2.4× 69 0.9× 100 1.7× 160 3.3× 20 0.5× 23 399
Alison Taylor United Kingdom 8 50 0.4× 80 1.0× 59 1.0× 57 1.2× 37 0.9× 17 439
Kelly Weigel United States 7 166 1.4× 46 0.6× 17 0.3× 196 4.0× 36 0.8× 11 505
Joseph A. Coladonato United States 8 241 2.1× 102 1.3× 94 1.6× 32 0.7× 10 0.2× 10 340
Adisorn Lumpaopong Thailand 11 113 1.0× 50 0.6× 22 0.4× 80 1.6× 14 0.3× 31 294
Frank Le Roy France 9 118 1.0× 43 0.5× 49 0.8× 74 1.5× 8 0.2× 18 365
I. Haddiya Morocco 9 82 0.7× 28 0.3× 20 0.3× 37 0.8× 10 0.2× 69 246
S Alloatti Italy 11 208 1.8× 58 0.7× 107 1.8× 68 1.4× 11 0.3× 56 290

Countries citing papers authored by Kay Tyerman

Since Specialization
Citations

This map shows the geographic impact of Kay Tyerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Tyerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Tyerman more than expected).

Fields of papers citing papers by Kay Tyerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Tyerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Tyerman. The network helps show where Kay Tyerman may publish in the future.

Co-authorship network of co-authors of Kay Tyerman

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Tyerman. A scholar is included among the top collaborators of Kay Tyerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Tyerman. Kay Tyerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagra, Arvind, Gary Connett, B. C. Reynolds, et al.. (2024). Fifteen-minute consultation: Empowering children, young people and families through shared decision-making: a practical guide. Archives of Disease in Childhood Education & Practice. 109(6). 264–270. 1 indexed citations
2.
Plumb, Lucy, Winnie Magadi, Anna Casula, et al.. (2022). Advanced chronic kidney disease among UK children. Archives of Disease in Childhood. 107(11). 1043–1045. 5 indexed citations
3.
Tyerman, Kay, et al.. (2022). A Case of Paediatric Anti-Glomerular Basement Membrane Disease Associated with Thrombotic Thrombocytopenic Purpura. Case Reports in Nephrology. 2022. 1–6. 2 indexed citations
4.
Tse, Yincent, Anne‐Sophie Darlington, Kay Tyerman, et al.. (2021). COVID-19: experiences of lockdown and support needs in children and young adults with kidney conditions. Pediatric Nephrology. 36(9). 2797–2810. 12 indexed citations
5.
Reynolds, B. C., et al.. (2021). UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology. 37(1). 199–207. 9 indexed citations
6.
Tse, Yincent, Anne‐Sophie Darlington, Kay Tyerman, et al.. (2021). 571 COVID-19: Experiences of lockdown and support needs in children and young adults with kidney conditions. Abstracts. A43.2–A43. 1 indexed citations
7.
Douthwaite, Sam, et al.. (2019). Clinical practice guideline management of blood borne viruses within the haemodialysis unit. BMC Nephrology. 20(1). 388–388. 24 indexed citations
8.
Dasgupta, Indranil, David Keane, Elizabeth Lindley, et al.. (2018). Validating the use of bioimpedance spectroscopy for assessment of fluid status in children. Pediatric Nephrology. 33(9). 1601–1607. 24 indexed citations
9.
Holmes, Jennifer, et al.. (2017). The incidence of pediatric acute kidney injury is increased when identified by a change in a creatinine-based electronic alert. Kidney International. 92(2). 432–439. 32 indexed citations
10.
Morgan, Jessica E., et al.. (2016). Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study. Pilot and Feasibility Studies. 2(1). 4–4. 2 indexed citations
11.
Hayes, Wesley, Rodney D. Gilbert, Stephen D. Marks, et al.. (2015). Positive trends in paediatric renal biopsy service provision in the UK: a national survey and re-audit of paediatric renal biopsy practice. Pediatric Nephrology. 31(4). 613–621. 8 indexed citations
12.
Stralen, Karlijn J. van, Kitty J. Jager, Sergey Baiko, et al.. (2013). Dyslipidaemia in children on renal replacement therapy. Nephrology Dialysis Transplantation. 29(3). 594–603. 14 indexed citations
13.
Amin, Nadia, Julian H. Barth, H P Field, et al.. (2013). Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinology Diabetes and Metabolism Case Reports. 2013. 130010–130010. 38 indexed citations
14.
Fitzpatrick, Maggie, K. Brownlee, Martin Elliott, et al.. (2010). Bilateral progressive cystic nephroma in a 9-month-old male infant requiring renal replacement therapy. Pediatric Nephrology. 25(9). 1755–1758. 10 indexed citations
15.
Phillips, Bob, et al.. (2008). A SYSTEMATIC REVIEW OF THE ACCURACY AND UTILITY OF EARLY MARKERS OF IFOSFAMIDE-INDUCED PROXIMAL TUBULOPATHY IN SURVIVORS OF CHILDHOOD CANCERS. Pediatric Hematology and Oncology. 25(2). 107–113. 4 indexed citations
16.
Phillips, Bob, Kay Tyerman, & Simon Whiteley. (2005). Use of antibiotics in suspected haemolytic-uraemic syndrome. BMJ. 330(7488). 409–410. 9 indexed citations
17.
18.
Ramage, Ian J., et al.. (2005). Vascular access survival in children and young adults receiving long-term hemodialysis. American Journal of Kidney Diseases. 45(4). 708–714. 54 indexed citations
19.
Tyerman, Kay, et al.. (1991). Donor pretreatment prolongs survival of discordant xenografts.. PubMed. 23(4). 2280–1. 3 indexed citations
20.
Tyerman, Kay, et al.. (1990). Prolongation of rat cardiac allograft survival by pretreatment of the donor to reduce class II antigen expression and dendritic cell content.. PubMed. 22(5). 2325–2325. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wai Leung Chak Breakdown of academic impact, for papers by L. Benamar Breakdown of academic impact, for papers by Covadonga Hevia Breakdown of academic impact, for papers by Alison Taylor Breakdown of academic impact, for papers by Kelly Weigel Breakdown of academic impact, for papers by Joseph A. Coladonato Breakdown of academic impact, for papers by Adisorn Lumpaopong Breakdown of academic impact, for papers by Frank Le Roy Breakdown of academic impact, for papers by I. Haddiya Breakdown of academic impact, for papers by S Alloatti
Rankless by CCL
2026